News for Sanofi Stock (SNY)

Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines

GlobeNewsWire • 05/10/24

INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX

Business Wire • 05/09/24

The 3 Most Undervalued Pharma Stocks to Buy in May 2024

InvestorPlace • 05/09/24

Sanofi's New Cancer Drug Could Help Deliver a Big Payday

The Motley Fool • 05/08/24

3 Biotech Stocks to Buy and Hold Through 2030 and Beyond

The Motley Fool • 05/02/24

Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations

GlobeNewsWire • 05/02/24

Press Release: Annual General Meeting of April 30, 2024

GlobeNewsWire • 04/30/24

Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up

Zacks Investment Research • 04/25/24

Sanofi (SNY) Q1 2024 Earnings Call Transcript

Seeking Alpha • 04/25/24

AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags

Investors Business Daily • 04/25/24

Sanofi Sales, Profit Beat Forecasts

WSJ • 04/25/24

Sanofi Q1 profit slips on generic competition, forex effects

Reuters • 04/25/24

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance

GlobeNewsWire • 04/25/24

What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?

Zacks Investment Research • 04/24/24

Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study

Zacks Investment Research • 04/23/24

FTC looking to accelerate inquiry into prescription-drug middlemen, chair says

Market Watch • 04/23/24

Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia

GlobeNewsWire • 04/23/24

Sanofi to overhaul US operations of vaccines, cut jobs

Reuters • 04/18/24

COTA Announces Strategic Collaboration with Sanofi to Leverage Real-World Data and AI to Accelerate Cancer Trials

Business Wire • 04/17/24

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis

GlobeNewsWire • 04/17/24

Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.

Market Watch • 04/16/24

Meet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.

Barrons • 04/09/24

Sanofi - AGM 30.04.2024 - Availability of Preparatory documents

GlobeNewsWire • 04/08/24

Sanofi Layoffs 2024: What to Know About the Latest SNY Job Cuts

InvestorPlace • 04/08/24

Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups

Business Wire • 04/05/24